Protoporphyrin Imaging in Multispectral Evaluation of Resections

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

May 1, 2026

Conditions
Glioma
Interventions
DEVICE

KINEVO 900 S with BLUE 400

The investigational device consists of a CE marked (MDR) surgical microscope KINEVO 900 S by Carl Zeiss Meditec AG, including the BLUE 400 fluorescence option. This microscope is equipped with an additional component (CALLAO), provided by the Carl Zeiss Meditec AG, that allows for extended, multispectral, image acquisition in the operating room. CALLAO consists of an optical setup with additional cameras, that can be mounted on the main system KINEVO 900 S, and a second light source for specific illumination during image acquisition with the CALLAO cameras.

Trial Locations (10)

Unknown

Universitätsklinik für Neurochirurgie der Medizinischen Universität Innsbruck, Innsbruck

Charité - Universitätsmedizin Berlin, Berlin

Universitätsklinikum Freiburg - Klinik für Neurochirurgie im Neurozentrum, Freiburg im Breisgau

Universitätsklinikum Göttingen - Neurochirurgische Klinik, Göttingen

Klinik und Poliklinik für Neurochirurgie, LMU Klinikum München, München

Klinikum rechts der Isar der Technischen Universität München, München

Universitätsklinikum Münster - Klinik für Neurochirurgie, Münster

Universitätsklinikum Tübingen, Universitätsklinik für Neurochirurgie, Tübingen

Inselspital Bern, Universitätsklinik für Neurochirurgie, Bern

Hôpitaux universitaires de Genève - NeuroCentre, Geneva

All Listed Sponsors
lead

Medical University Innsbruck

OTHER

NCT07021573 - Protoporphyrin Imaging in Multispectral Evaluation of Resections | Biotech Hunter | Biotech Hunter